(Q33239855)

24 July 2017

1 reference

title

Treatment of primary intraocular melanoma (English)

1 reference

24 July 2017

Bertil Damato

1

1 reference

24 July 2017

1 April 2006

1 reference

Expert Review of Anticancer Therapy

24 July 2017

1 reference

24 July 2017

6

1 reference

24 July 2017

4

1 reference

24 July 2017

493-506

1 reference

Nondiagnosed uveal melanomas

24 July 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Mode of presentation and time to treatment of uveal melanoma in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Uveal melanoma: epidemiologic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Sunlight exposure and pathogenesis of uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Very long-term prognosis of patients with malignant uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Vasculogenic mimicry and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Uveal melanoma: genetic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

A prognostic model and staging for metastatic uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Secondary retinal changes associated with choroidal naevi and melanomas documented by optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Whole body PET/CT imaging for detection of metastatic choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Conformal episcleral plaque therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Results of treatment of choroidal malignant melanoma with high-dose-rate strontium-90 brachytherapy. A retrospective study of 46 patients treated between 1983 and 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Local tumor control after 106Ru brachytherapy of choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Improved treatment planning for COMS eye plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Uveal melanoma: proton beam irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Risk factors for radiation maculopathy and papillopathy after intraocular irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Infrared thermotherapy: from laboratory to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Adjuvant indocyanine green in transpupillary thermotherapy for choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Predictive factors of visual outcome after local resection of choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Risk factors for metastatic uveal melanoma after trans-scleral local resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Endoresection of choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Histopathology of eyes enucleated after endoresection of choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Intrascleral recurrence of uveal melanoma after transretinal "endoresection".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Reduced melanoma-related mortality in uveal melanoma by preenucleation radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Metastatic uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Quality of life in patients with malignant choroidal melanoma after radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Risk of ocular melanoma in relation to cutaneous and IRIS naevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Detection of uveal melanoma by optometrists in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Delays in the diagnosis of uveal melanoma and effect on treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Intraoperative echographic localization of iodine-125 episcleral plaque for brachytherapy of choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Palladium-103 plaque radiotherapy for choroidal melanoma: an 11-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Plaque radiation therapy for malignant melanoma of the iris and ciliary body

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Proton beam radiotherapy of iris melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

[Stereotactic radiosurgery using the Gamma Knife for large uveal melanomas]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

LINAC based stereotactic radiotherapy of uveal melanoma: 4 years clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Extrascleral extension of choroidal malignant melanoma following transpupillary thermotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

[Endoscopic resection of malignant melanomas of the uvea after preoperative stereotactic single dose convergence irradiation with the Leksell gamma knife]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

Protracted survival after resection of metastatic uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.493

21 January 2018

Identifiers

DOI

10.1586/14737140.6.4.493

1 reference

24 July 2017

1 reference

PubMed ID

16613538